Align Technology | ALGN - Sales Revenues

Stock Price
163.10
Daily Change
0.07 0.04%
Monthly
1.85%
Yearly
-24.43%
Q1 Forecast
158.01

Align Technology reported $995.7M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
3M USD 6.1B 200M Dec/2025
Align Technology USD 995.7M 14.3M Sep/2025
Becton, Dickinson and Co. USD 5.9B 400M Sep/2025
Bruker USD 860.5M 63.1M Sep/2025
Cardinal Health USD 64B 3.8B Sep/2025
Charles River Laboratories USD 1000M 32.14M Sep/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
CVS Health USD 102.9B 3.99B Sep/2025
Danaher USD 6.84B 790M Dec/2025
Dentsply International USD 904M 32M Sep/2025
Dexcom USD 1.21B 50M Sep/2025
Henry Schein USD 3.34B 100M Sep/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Insulet USD 706.3M 57.2M Sep/2025
Integra LifeSciences USD 402.06M 13.54M Sep/2025
IQVIA Holdings USD 4.1B 80M Sep/2025
Masimo USD 371.5M 600K Sep/2025
McKesson USD 103.15B 5.32B Sep/2025
Mettler Toledo International USD 1.03B 46.78M Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
Solventum Corp USD 2.1B 60M Sep/2025
Stryker USD 7.2B 1.14B Dec/2025
Teleflex USD 913M 132.11M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Veeva Systems USD 811.24M 22.15M Sep/2025
Waters USD 800M 29M Sep/2025
Zimmer Biomet Holdings USD 2B 80M Sep/2025
Zoetis USD 2.4B 60M Sep/2025